Evidence map›Paper›PMID 27989687›Full record

ArticleHeart rhythm2017

Role of protein kinase C in metabolic regulation of the cardiac Na

Man Liu, Guangbin Shi, Kai-Chien Yang, Lianzhi Gu, Anumantha G Kanthasamy, Vellareddy Anantharam, Samuel C Dudley

Abstract read
In one paragraph

Article in Heart rhythm, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Modulation of NOX2 causes obesity-mediated atrial fibrillation.The Journal of clinical investigation · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation.Circulation. Arrhythmia and electrophysiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Man LiuDivision of Cardiology, Department of Medicine, The Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island.
Guangbin ShiDivision of Cardiology, Department of Medicine, The Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island.
Kai-Chien YangDivision of Cardiology, Department of Medicine, The Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island; Graduate Institute of Pharmacology, National Taiwan University School of Medicine, Taipei City, Taiwan.
Lianzhi GuSection of Cardiology, University of Illinois at Chicago, Chicago, Illinois.
Anumantha G KanthasamyDepartment of Biomedical Sciences, Iowa Center for Advanced Neurotoxicology, Iowa State University, Ames, Iowa.
Vellareddy AnantharamDepartment of Biomedical Sciences, Iowa Center for Advanced Neurotoxicology, Iowa State University, Ames, Iowa.
Samuel C DudleyDivision of Cardiology, Department of Medicine, The Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island; Providence VA Medical Center, Providence, Rhode Island. Electronic address: samuel_dudley@brown.edu.
Brown University · USIowa State University · USNational Taiwan University · TWUniversity of Illinois Chicago · US

Funding

MMT, DOPAMINERGIC DEGENERATION, AND AGINGR01ES010586 · NIEHS · IOWA STATE UNIVERSITY · PI KANTHASAMY, ANUMANTHA GOUNDER · 2000 to 2015
$4.6M
Na+ channel mRNA splicing in heart failureR01HL104025 · NHLBI · UNIVERSITY OF MINNESOTA · PI DUDLEY, SAMUEL C · 2011 to 2019
$3.3M
Metabolic Regulation of Sodium ChannelsR01HL106592 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDLEY, SAMUEL C · 2011 to 2014
$1.6M
NHLBI NIH HHS R01 HL104025NHLBI NIH HHS R01 HL106592NIEHS NIH HHS R01 ES010586
6 · The paper itself

Abstract

backgroundThe reduced form of nicotinamide adenine dinucleotide (NADH) increases in cardiomyopathy, activates protein kinase C (PKC), up-regulates mitochondrial reactive oxygen species (mitoROS), and down-regulates the cardiac Na

objectiveThe purpose of this study was to determine how NADH signals down-regulation of Na

methodsIsolated mouse cardiomyocytes were used for patch-clamp recording and for monitoring mitoROS with MitoSOX Red. HEK293 cells were used for transient transfections. HEK293 cells stably expressing human Na

resultsNADH enhanced PLD activity (1.6- ± 0.1-fold, P <.01) and activated PKCδ. Activated PKCδ translocated to mitochondria and up-regulated mitoROS (2.8- ± 0.3-fold, P <.01) by enhancing the activities of mitochondrial complexes I, II, and IV (1.1- to 1.5-fold, P <.01). PKCδ also interacted with Na

conclusionNADH activated PKCδ by enhancing PLD activity. PKCδ modulated both mitoROS and Na

Indexed as

AnimalsArrhythmias, CardiacCells, CulturedDown-RegulationMiceMitochondria, HeartMyocytes, CardiacNADNAV1.5 Voltage-Gated Sodium ChannelPhosphorylationProtein Kinase CReactive Oxygen SpeciesNADNAV1.5 Voltage-Gated Sodium ChannelProtein Kinase Cprotein kinase DReactive Oxygen SpeciesArrhythmiaCardiomyopathyChannel phosphorylationMetabolismMitochondriaNicotinamide adenine dinucleotideProtein kinase Cδ

Identifiers

PMID27989687
PMCPMC5316355
OpenAlexW2564384329

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.